Monday, March 11, 2019

Product developed at LA BioMed is a safe, economical, available primary therapy

Investigator(s):
Investigator(s): Yutaka Niihara, MD, MPH
Research Theme(s): Infection and Immunity

Last night’s episode of CBS’ “60 Minutes” brought much-needed awareness of the hardships faced by the estimated 25 million people around the world living with sickle cell disease. The broadcast highlighted an experimental gene therapy-based treatment that might someday even cure the disease. However, at this time, it is not available to the general public and remains in an experimental stage where potential complications and consistent efficacy are still being evaluated. Also, the procedure is potentially hugely expensive should it ever be commercialized.

Thursday, November 1, 2018
Investigator(s):

While male and female surgeons both work equally hard saving lives in the operating room, women in general surgery project earning significantly less than men. This disparity is due to women underestimating their future earning power, and to differing approaches to salary negotiation, according to an important new study from LA BioMed, an independent non-profit biomedical research organization.

Tuesday, October 23, 2018
Investigator(s):
Investigator(s): Loren Miller, MD, MPH
Research Theme(s): Infection and Immunity

Taking aim at one of the nation’s most common - but understudied - diseases, a team of local investigators have launched a groundbreaking study to determine the effectiveness of treatments for antibiotic-resistant skin infections.

The investigators from LA BioMed, one of the nation’s leading independent nonprofit research institutes, have been awarded a $5.3 million grant from the National Institutes of Health for their study, Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment.

Tuesday, October 16, 2018
Investigator(s):
Investigator(s): Ashraf Ibrahim, PhD
Research Theme(s): Infection and Immunity

Mucormycosis is a drug-resistant fungal infection that attacks patients with weakened immune systems and those who have suffered significant trauma. The infection can be easily missed by physicians because it is so rare and reliable diagnostic assay is lacking. Even when correctly diagnosed, it is often far too late and after the infection has spreads rapidly to vital organs, making most therapies ineffective. The mortality rate for those infected with mucormycosis is around 50%, according to the U.S. centers for Disease Control and Prevention.

Wednesday, June 20, 2018
Investigator(s):
Dr. Rie Sakai-Bizmark A researcher from LA BioMed has been awarded $688,013 in grant funding from the National Institutes of Health to improve newborn infant screening.
Monday, June 10, 2013
Investigator(s):
Investigator(s): Virender Rehan, MD

Turmeric, a key ingredient in spicy curry dishes, has long been known to have medicinal values. Now new research finds a substance in turmeric, curcumin, may provide lasting protection against potentially deadly lung damage in premature infants.